CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Vical, Inc. develops biopharmaceutical products based on our patented naked DNA gene transfer technologies for the prevention and treatment of life-threatening diseases. We currently focus our development on innovative cancer therapies designed to in...Show all
Company (IPO / Went public)
Phone:
San Diego, 92121
California, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compositions and methods for vaccinating against hsv-2 | Sep 12, 2014 | Dec 08, 2015 | Patent |
| Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection | Feb 10, 2014 | Nov 10, 2015 | Patent |
| Compositions and methods for vaccinating against hsv-2 | Aug 14, 2014 | Oct 20, 2015 | Patent |
| Compositions and methods for enhancing immune responses to vaccines | Mar 15, 2013 | Aug 11, 2015 | Patent |
| Compositions and methods for enhancing immune responses to vaccines | Aug 03, 2012 | Apr 07, 2015 | Patent |
